CD19 and neoplasm: We also observed no significant differences in tumour control (Extended Data Fig. 5h) or in NFAT-driven luciferase activity (Extended Data Fig. 5i,j) for 4G anti-CD19 CAR-T cells generated with virus produced in the presence or absence of Tax and NovB2.